Gufic BioSciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

9.69

9.69

9.69

9.69

7.78

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

338.11

259.42

163.74

119.63

67.56

Loan funds

Secured loans

311.41

61.24

51.75

112.65

96.00

Unsecured loans

-

-

-

-

-

Total

659.22

330.36

225.19

241.97

171.35

Uses of funds

Fixed assets

Gross block

227.89

168.24

148.18

114.63

36.95

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

68.32

53.07

48.21

32.04

12.50

Net block

159.57

115.17

99.97

82.58

24.45

Capital work-in-progress

169.59

40.87

13.40

30.61

9.63

Investments

0.78

0.01

0.01

0.01

0.01

Net current assets

Current assets, loans & advances

531.22

365.35

278.68

294.32

245.46

Less : current liabilities & provisions

201.94

191.04

166.87

165.55

108.19

Total net current assets

329.27

174.31

111.81

128.77

137.27

Miscellaneous expenses not written

-

-

-

-

-

Total

659.22

330.36

225.19

241.97

171.35

Notes:

Book value of unquoted investments

0.78

0.01

0.01

0.01

0.01

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

27.87

100.51

16.20

47.46

9.40

Number of equity sharesoutstanding (Lacs)

969.45

969.45

969.45

969.45

778.30